The Canadian Rheumatology Association would like to advise its members of the following reported drug shortage:

Drug Name: CHLOROQUINE DIPHOSPHATE                                                                                   

Date Shortage Reported: July 2019                                          

Expected Resolution of Shortage: No resolution expected. Officially termed an ‘Extended Disruption.’

Provinces Affected: All

Additional Comments: 

While being called an ‘extended disruption’, this is really a discontinuation as the manufacturer (Teva) plans to discontinue it in Canada.

Some members and patients may still be able to access if local pharmacy has shelf stock.